Avoiding Guillan-Barré Syndrome following swine origin pandemic H1N1 2009 influenza vaccination.
Eisen
Damon P
DP
McBryde
Emma S
ES
D000818:Animals; D016537:Gangliosidosis, GM1 / Q000276:immunology; D020275:Guillain-Barre Syndrome / Q000517:prevention & control*; D006389:Hemagglutinins, Viral / Q000276:immunology*; D006801:Humans; D017589:Immunization Programs; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000009:adverse effects*; D007251:Influenza, Human; D051379:Mice; D019158:N-Acetylneuraminic Acid / Q000276:immunology; D011358:Product Surveillance, Postmarketing
D006389:Hemagglutinins, Viral; D007252:Influenza Vaccines; D019158:N-Acetylneuraminic Acid